NEW YORK (GenomeWeb) – Using newly-developed software called Matched Interactions across Tissues or MixT, an international team of researchers has shown links between molecular processes in breast cancer and immune system cells in the blood that they say could result in new ways to treat and monitor breast cancer.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.